# The Chimerix CMX001 Registry

> **NCT02167685** · — · TERMINATED · sponsor: **Jazz Pharmaceuticals** · enrollment: 550 (estimated)

## Conditions studied

- Outcomes
- Survival Rates

## Interventions

- **DRUG:** CMX001

## Key facts

- **NCT ID:** NCT02167685
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-10
- **Target enrollment:** 550 (ESTIMATED)
- **Why stopped:** terminated due to low enrollment rate
- **Last updated:** 2019-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02167685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02167685, "The Chimerix CMX001 Registry". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02167685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*